• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨外黏液样软骨肉瘤中EWS/CHN和RBP56/CHN融合基因的分子遗传学特征

Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma.

作者信息

Panagopoulos Ioannis, Mertens Fredrik, Isaksson Margareth, Domanski Henryk A, Brosjö Otte, Heim Sverre, Bjerkehagen Bodil, Sciot Raf, Dal Cin Paola, Fletcher Jonathan A, Fletcher Christopher D M, Mandahl Nils

机构信息

Department of Clinical Genetics, Lund University Hospital, Lund, Sweden.

出版信息

Genes Chromosomes Cancer. 2002 Dec;35(4):340-52. doi: 10.1002/gcc.10127.

DOI:10.1002/gcc.10127
PMID:12378528
Abstract

Extraskeletal myxoid chondrosarcoma (EMC) is a soft-tissue neoplasm cytogenetically characterized by the translocations t(9;22)(q22;q11-12) or t(9;17)(q22;q11), generating EWS/CHN or RBP56/CHN fusion genes, respectively. In the present study, 18 EMCs were studied both cytogenetically and at the molecular level. Chromosomal aberrations were detected in 16 samples: 13 with involvement of 9q22 and 22q11-12, and three with rearrangements of 9q22 and 17q11. Fifteen cases had an EWS/CHN fusion transcript and three had an RBP56/CHN transcript. The most frequent EWS/CHN transcript (type 1; 10 tumors), involved fusion of EWS exon 12 with CHN exon 3, and the second most common (type 5; two cases) was fusion of EWS exon 13 with CHN exon 3. In all tumors with RBP56/CHN fusion, exon 6 of RBP56 was fused to exon 3 of CHN. By genomic XL PCR and sequence analyses, the breakpoints from 14 cases were mapped in the EWS, RBP56, and CHN genes. In CHN, 12 breakpoints were found in intron 2 and only two in intron 1. In EWS, the breaks occurred in introns 7 (one break), 12 (eight breaks), and 13 (one break), and in RBP56 in intron 6. Repetitive elements such as Alu and LINE sequences seem to have limited, if any, importance in the genesis of EWS/CHN and RBP56/CHN chimeras. Furthermore, there were no chi, chi-like, topoisomerase II, or translin consensus sequences in the introns harboring the translocation breakpoints, nor could the number of topo I sites in EWS, RBP56, and CHN introns explain the uneven distribution of the breakpoints among EWS or CHN introns. Additional genetic events, such as nucleotide insertions, homologies at the junction, deletions, duplications, and inversions, were found to accompany the translocations, indicating that the chromosomal translocations do not require sequence-specific recombinases or extensive homology between the recombined sequences.

摘要

骨外黏液样软骨肉瘤(EMC)是一种软组织肿瘤,其细胞遗传学特征为易位t(9;22)(q22;q11 - 12)或t(9;17)(q22;q11),分别产生EWS/CHN或RBP56/CHN融合基因。在本研究中,对18例EMC进行了细胞遗传学和分子水平的研究。在16个样本中检测到染色体畸变:13例涉及9q22和22q11 - 12,3例涉及9q22和17q11的重排。15例有EWS/CHN融合转录本,3例有RBP56/CHN转录本。最常见的EWS/CHN转录本(1型;10个肿瘤)涉及EWS外显子12与CHN外显子3的融合,第二常见的(5型;2例)是EWS外显子13与CHN外显子3的融合。在所有具有RBP56/CHN融合的肿瘤中,RBP56的外显子6与CHN的外显子3融合。通过基因组XL PCR和序列分析,14例病例的断点定位在EWS、RBP56和CHN基因中。在CHN中,12个断点位于内含子2,仅2个位于内含子1。在EWS中,断点发生在内含子7(1个断点)、12(8个断点)和13(1个断点),在RBP56中发生在内含子6。诸如Alu和LINE序列等重复元件在EWS/CHN和RBP56/CHN嵌合体的发生中似乎作用有限(如果有作用的话)。此外,在含有易位断点的内含子中没有chi、chi样、拓扑异构酶II或转座蛋白共有序列,EWS、RBP56和CHN内含子中的拓扑异构酶I位点数量也无法解释EWS或CHN内含子中断点的不均匀分布。发现伴随易位出现了其他遗传事件,如核苷酸插入、连接处的同源性、缺失、重复和倒位,这表明染色体易位不需要序列特异性重组酶或重组序列之间的广泛同源性。

相似文献

1
Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma.骨外黏液样软骨肉瘤中EWS/CHN和RBP56/CHN融合基因的分子遗传学特征
Genes Chromosomes Cancer. 2002 Dec;35(4):340-52. doi: 10.1002/gcc.10127.
2
Fusion of the RBP56 and CHN genes in extraskeletal myxoid chondrosarcomas with translocation t(9;17)(q22;q11).具有t(9;17)(q22;q11)易位的骨外黏液样软骨肉瘤中RBP56和CHN基因的融合
Oncogene. 1999 Dec 9;18(52):7594-8. doi: 10.1038/sj.onc.1203155.
3
Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 18 cases.骨外黏液样软骨肉瘤:18例临床病理、免疫组化及分子分析
Hum Pathol. 2001 Oct;32(10):1116-24. doi: 10.1053/hupa.2001.28226.
4
Identification of a novel fusion gene involving hTAFII68 and CHN from a t(9;17)(q22;q11.2) translocation in an extraskeletal myxoid chondrosarcoma.在一例骨外黏液样软骨肉瘤中,通过t(9;17)(q22;q11.2)易位鉴定出一种涉及hTAFII68和CHN的新型融合基因。
Oncogene. 1999 Dec 9;18(52):7599-601. doi: 10.1038/sj.onc.1203156.
5
Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma.骨外黏液样软骨肉瘤中EWS相关基因TAF2N与TEC的融合
Cancer Res. 1999 Oct 15;59(20):5064-7.
6
Characteristic sequence motifs at the breakpoints of the hybrid genes FUS/CHOP, EWS/CHOP and FUS/ERG in myxoid liposarcoma and acute myeloid leukemia.黏液样脂肪肉瘤和急性髓性白血病中融合基因FUS/CHOP、EWS/CHOP和FUS/ERG断点处的特征性序列基序。
Oncogene. 1997 Sep;15(11):1357-62. doi: 10.1038/sj.onc.1201281.
7
Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.EWS/Fli1易位各种外显子组合的鉴定:一种针对石蜡包埋组织的优化逆转录聚合酶链反应方法——CWS研究小组的报告
Klin Padiatr. 2004 Nov-Dec;216(6):315-22. doi: 10.1055/s-2004-832338.
8
The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomas.同源异型蛋白Six3是核受体NOR-1的共激活因子,也是人类骨外黏液样软骨肉瘤中融合蛋白EWS/NOR-1的共抑制因子。
Cancer Res. 2003 Jan 15;63(2):449-54.
9
Molecular characterization of the genomic breakpoint junction in a t(11;22) translocation in Ewing sarcoma.尤因肉瘤中t(11;22)易位的基因组断点连接的分子特征分析
Genes Chromosomes Cancer. 1999 May;25(1):6-15.
10
Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma.骨外黏液样软骨肉瘤中EWS与一个孤儿核受体基因融合的分子分析。
Am J Pathol. 1997 Mar;150(3):1049-58.

引用本文的文献

1
Whole genome sequencing for metastatic mutational burden in extraskeletal myxoid chondrosarcoma.全基因组测序用于检测骨外黏液样软骨肉瘤转移灶的突变负荷
Front Mol Med. 2023 Jul 24;3:1152550. doi: 10.3389/fmmed.2023.1152550. eCollection 2023.
2
Genetic Pathways in Peritoneal Mesothelioma Tumorigenesis.腹膜间皮瘤发生的遗传途径。
Cancer Genomics Proteomics. 2023 Jul-Aug;20(4):363-374. doi: 10.21873/cgp.20388.
3
NR4A3 Expression Is Consistently Absent in Acinic Cell Carcinomas of the Breast: A Potential Nosologic Shift.NR4A3 表达在乳腺涎腺型癌中始终缺失:一种潜在的分类学转变。
Mod Pathol. 2023 Jun;36(6):100144. doi: 10.1016/j.modpat.2023.100144. Epub 2023 Feb 22.
4
Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Soft Tissue Tumors.《世界卫生组织头颈部肿瘤分类(第 5 版)更新:软组织肿瘤》。
Head Neck Pathol. 2022 Mar;16(1):87-100. doi: 10.1007/s12105-022-01425-w. Epub 2022 Mar 21.
5
Primary intracranial extra-skeletal myxoid chondrosarcoma of right lateral ventricle with EWSR1 gene fusion: a case report and review of literature.右侧脑室原发性颅内骨外黏液样软骨肉瘤伴EWSR1基因融合:一例报告及文献复习
Ecancermedicalscience. 2021 Jun 30;15:1257. doi: 10.3332/ecancer.2021.1257. eCollection 2021.
6
Survey of Paediatric Oncologists and Pathologists regarding Their Views and Experiences with Variant Translocations in Ewing and Ewing-Like Sarcoma: A Report of the Children's Oncology Group.儿童肿瘤学组关于儿科肿瘤学家和病理学家对尤因肉瘤及尤因样肉瘤中变异易位的观点和经验的调查:一份报告
Sarcoma. 2020 Dec 5;2020:3498549. doi: 10.1155/2020/3498549. eCollection 2020.
7
Extraskeletal Myxoid Chondrosarcoma: State of the Art and Current Research on Biology and Clinical Management.骨外黏液样软骨肉瘤:生物学与临床管理的最新进展及当前研究
Cancers (Basel). 2020 Sep 21;12(9):2703. doi: 10.3390/cancers12092703.
8
Extraskeletal Myxoid Chondrosarcoma: Long-Term Survival in the Setting of Metastatic Disease.骨外黏液样软骨肉瘤:转移性疾病背景下的长期生存情况
Case Rep Orthop. 2020 Sep 5;2020:2684746. doi: 10.1155/2020/2684746. eCollection 2020.
9
The new horizon of liquid biopsy in sarcoma: the potential utility of circulating tumor nucleic acids.肉瘤液体活检的新视野:循环肿瘤核酸的潜在效用
J Cancer. 2020 Jul 9;11(18):5293-5308. doi: 10.7150/jca.42816. eCollection 2020.
10
Extraskeletal Myxoid Chondrosarcomas: Combined Modality Therapy With Both Radiation and Surgery Improves Local Control.骨外黏液样软骨肉瘤:联合放射和手术的综合治疗可改善局部控制。
Am J Clin Oncol. 2019 Oct;42(10):744-748. doi: 10.1097/COC.0000000000000590.